Keros Therapeutics (NASDAQ:KROS) Hits New 52-Week Low – Here’s Why
otakuyassine3@gmail.com Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) hit a new 52-week low during trading...
Keros
Keros Therapeutics, Inc. (NASDAQ:KROS) Receives $81.33 Consensus Price Target from Analysts
Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) has earned a consensus recommendation of “Moderate...